HelixNano Company

Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases. HelixNano is a Y Combinator and venture backed biotech startup. At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. We’re moving fast but thinking long-term. We’re already testing COVID-19 vaccine candidates designed to be precise and safe. Our next goal is to create a vaccine that protects everyone not only from this virus, but all future coronaviruses.

Technology: AI-driven Drug Target Identification
Industry: BioPharma AI
Founded Date: 2013-01-01 00:00:00
Headquarters: Cambridge,Massachusetts,United States,North America
Funding Status: private